Evidence map›Paper›PMID 33344790›Full record

ArticleHeliyon2020

Investigation on penetration of saffron components through lipid bilayer bound to spike protein of SARS-CoV-2 using steered molecular dynamics simulation.

Azadeh Kordzadeh, Ahmad Ramazani Saadatabadi, Amin Hadi

Abstract read
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Analytical review ofJournal of herbal medicine · 2023
    Review
  8. Small molecules in the treatment of COVID-19.Signal transduction and targeted therapy · 2022
    Review
  9. Article
  10. Article
  11. Review
  12. Liposomal Saffron: A Promising Natural Therapeutic and Immune-Boosting Agent.International journal of preventive medicine · 2022
    Article
  13. Review
  14. Saffron forMetabolism open · 2021
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Azadeh KordzadehChemial and Petroleum Egineering Department, Sharif University of Technology, Tehran, Iran.
Ahmad Ramazani SaadatabadiChemial and Petroleum Egineering Department, Sharif University of Technology, Tehran, Iran.
Amin HadiCellular and Molecular Research Center, School of Medicine, Yasuj University of Medical Sciences, Yasuj, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A coronavirus identified as COVID-19 is the reason for an infection outbreak which is started in December 2019. NO completely effective drugs and treatments are not recognized for this virus. Recently, saffron and its compounds were used to treat different viral diseases. Saffron extract and its major ingredients have shown antiviral effects. In this study, the steered molecular dynamics simulation was used for investigating the effect of four main components of saffron that include: crocin, crocetin, safranal, and picrocrocin as candidate for drug molecules, on COVID-19. The binding energies between drug molecules and spike protein and the main protease of the virus were evaluated. The obtained results based on Lennard-Jones and electrostatic potentials demonstrated that crocetin has a high affinity towards spike protein and also the main protease of the virus. Also, the quantum mechanics calculations elucidated that the crocetin could overcome energy barrier of lipid bilayer with strong dipole moment and polarizability. The pharmacokinetic and ADMET properties proved that crocetin could be a suitable drug candidate. So, crocetin could be a promising drug for treatment of COVID-19.

Indexed as

BioinformaticsBiomedical engineeringBiotechnologyCrocetinCrocinMolecular biologyMolecular dynamics simulationPicrocrocinProteinsSafranalSARS-CoV-2

Identifiers

PMID33344790
PMCPMC7733551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.